Background: Researcher showed that EPO is a relatively accurate marker of eosinophilia
Introduction
Eosinophilia and eosinophil degranulation in target tissues are major pathological mechanisms in allergic diseases such as allergic rhinitis, asthma, and atopic dermatitis. 1, 2) Allergic rhinitis is characterized by inflammation associated with eosinophilia in the nasal mucosa and secretions. Hence, measurements of nasal eosinophils have been suggested as a useful diagnostic tool in patients with allergic rhinitis and chronic rhinitis. [3] [4] [5] However, the need for more sensitive and reproducible tests for eosinophilic inflammation has been raised since eosinophil counts can vary depending on the experience and skills of the investigator. 6, 7) In addition, it was suggested that nasal eosinophilia was not a sensitive or useful diagnostic tool for allergic rhinitis in children demonstrating the limitations of measuring of nasal eosinophil in clinical practice for children. 8) To address these limitations, researchers have tried to identify eosinophilic inflammation by measuring the eosinophil-specific toxic granules released into lesion tissues instead of measuring the eosinophil counts. 9, 10) Eosinophils have toxic granules containing major basic proteins 1 and 2, eosinophil peroxidase (EPO), eosinophil derived neurotoxin (EDN), and eosinophil cationic protein (ECP). These granules are released and are deposited in lesion tissues. 2) EDN and ECP are secreted by neutrophils and eosinophils. Whereas, EPO, the most abundant cationic protein in toxic granules, is a toxic protein secreted only by eosinophils and used as an eosinophil specific marker. 11) EPO level was suggested as a relatively accurate marker for eosinophilia and eosinophil activity in the sputum because EPO compared to EDN and ECP has a higher correlation to sputum eosinophilia. 6) Eosinophil count in sputum also showed a close correlation with nasal eosinophil count and nasal EPO level as well as sputum EPO. [12] [13] [14] Eosinophil granules, such as EPO, are released in the target tissue by degranulation and cause injury and pathogenic effect. 15, 16) symptoms with associated sinusitis such as persistent headache and positive x-ray finding of paranasal sinus were detected. Acute sinusitis combined with lower respiratory infection such as bronchitis or pneumonia was also included in this case group. Immunosuppressed patients or whose specimens had not been properly tested were excluded.
We excluded 32 patients: 31 whose specimens were refrigerated for a day instead of being frozen immediately, and one who was immunosuppressed. The results of 67 patients who met the inclusion criteria were analyzed.
Measurement of nasal eosinophil
The nasal mucosa of the lower turbinate area was rubbed with a cotton swab, and nasal secretions were smeared onto microscope slides and stained with Wright stains. The total cell 
Measurement of EPO
The cotton swab was placed in a 15 ml falcon tube, following which it was smeared on to the slide. One milliliter of normal saline was added to the tube and mixed at the maximum intensity in a vortex mixer. It was then left at room temperature for 30 minutes to one hour. 
A c c e p t e d
A r t i c l e Patients with allergic rhinitis and suspected allergic rhinitis regardless of the accompanying infection, made up two-thirds of the patients. And this group was classified as the allergic rhinitis group (Group A) whereas all others were classified as non-allergic rhinitis group (Group B) ( Table 1 ).
Correlation between nasal eosinophil and other parameters
There was a statistically significant correlation between the eosinophil count and percentage (P <0.001, Figure 1) . However, the eosinophil percentage and EPO did not correlate ( Figure   2 ). The eosinophil count and EPO had a statistically significant correlation (Figure 3 ).
Group A showed a statistically higher eosinophil count (P= 0.024) and percent (P= 0.011) compared to group B. However, there was no statistically significance of EPO between these groups even though median EPO value was higher in group A. The number of subjects that has a nasal eosinophil counts above 2 and 5 were 19 and 14, respectively. Among them, the
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A r t i c l e number of subjects belonging to group A was 17 (89.5%) and 13 (92.9%), respectively, which was statistically higher than group B ( Table 2) . The difference in EPO values between the groups above and those below the nasal counts of 2, 5, 10, and 20 were statistically significant ( Table 3 ). The EPO cut-off value examined for nasal eosinophil counts were 2, 5, 10, and 20 was 17.57 ng/μg regardless of the reference count. The largest area under curve (AUC) value was obtained when the receiver operating characteristic (ROC) curve was drawn using the eosinophil count of 2 ( Figure 4) .
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Discussion
Nasal eosinophils reflect allergic inflammation in the nose. 4, [18] [19] [20] In one study, nasal mucosal biopsy was performed from patients with seasonal allergic rhinitis sensitized to grass pollen before administration, and 1 hour, 24 hours, and 1 week after administration of the allergen.
The nasal eosinophil count significantly increased after provocation with the allergen when compared to the count before provocation.
18) The nasal eosinophil percentage in patients with allergic rhinitis was significantly higher than that in healthy controls and patients with other nasal diseases. 19) Our result also showed that nasal eosinophil count and percentage was higher in group A. However, EPO was not significantly higher in Group A than Group B.
This may suggest that even if eosinophils increase in allergic rhinitis, it does not indicated the activation of eosinophilic inflammation. There are insufficient absolute criteria for nasal eosinophilia to predict allergic inflammation. Several studies use different criteria for nasal eosinophilia. Nasal eosinophilia has been defined as eosinophils greater than 5% by 25) Our study showed that it would be appropriate to consider the criteria for nasal eosinophilia in children as nasal eosinophil count of more than 2 or 5, because a significant statistical difference was shown between group A and group B, according to below and above nasal eosinophil counts of 2 and 5. In our study, forty-eight patients (71.6%) had nasal eosinophil counts of less than 1. The maximum percentage of
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nasal eosinophils was only 8%. These results suggest that it may be reasonable to apply the criteria for nasal allergic inflammation according to the nasal eosinophil count, as in
Meltzer's study, 25) rather than previous studies 17,21-,24) which suggest that percentages of 10%, 20%, or 25% represent nasal eosinophilia. In addition, EPO values had a stronger correlation with nasal eosinophil counts than percentages (Fig. 2) , suggesting that the count is more sensitive to allergic inflammation than the percentage. Eosinophilic toxic granules such as ECP or EPO, which indicate eosinophil activation, have been studied. 6, 7, 9, 10, 15, 16) In one study, the eosinophil count and EPO of the bronchoalveolar lavage solution did not increase in patients with asthma after saline administration, but increased 24 hours after allergen challenges. 26) In patients with seasonal allergic rhinitis, eosinophil counts were significantly increased in the nasal mucosal biopsies, and extracellular EPO and ECP were more frequent after allergen provocation tests than before. 15) This indicates a close correlation between nasal eosinophil counts and eosinophil-specific EPO concentrations, suggesting that EPO can replace nasal eosinophil counts and represent activated states of allergic inflammation well.
The aim of the present study was to evaluate the correlation between nasal eosinophil counts and EPO values in patients with repeated nasal symptoms without defining a limited disease category, such as allergic rhinitis because allergic rhinitis is based on a clinical diagnosis and even in allergic rhinitis, nasal eosinophil counts and EPO may or may not have increased depending on the timing of the tests. We also investigated the cut-off value of nasal EPO for nasal eosinophilia using reference nasal eosinophil counts established as nasal eosinophilia..
Since there are not many studies on this subject, especially in pediatric patients, it is meaningful to be able to confirm the expression patterns of eosinophils and EPO in the presence of rhinitis. In addition, we presented the use of EPO as a practical diagnostic test by using an ELISA method which makes it easier and less costly to test EPO and compare with the EPO value corrected by proteins in nasal discharge to calibrate the amount of nasal
discharge. This method can reduce the possibility of errors that can be associated with measuring EPO higher or lower than the real value by the amount of nasal discharge.
In this study, a significant correlation was found between the nasal eosinophil count and EPO value ( Table 2 ). There were a statistically significant differences in the EPO values between the groups above and below the reference levels when the nasal eosinophil counts were 2, 5, 
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